Delivery Order SPE2DB24D3013-SPE2DB25FFQKA
- Not listed
- The Defense Logistics Agency awarded a $2,395.86 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $3,558.49 under a firm fixed-price contract. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical product is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Escitalopram 20 mg tablets in a quantity of 1,000 units, with a firm fixed price ceiling value of $4,295.66. The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- The Defense Logistics Agency awarded a $4,884.40 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with completion required by September 9, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $10,145.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of 1,000 tablets of Escitalopram 20 mg, with an ultimate completion date of September 11, 2025. This non-set-aside contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.89 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a $1,627.52 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with performance scheduled for completion by September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. This award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg on July 29, 2025, with a ceiling value of $2,187.18 and an ultimate completion date of July 30, 2025. The contract carries a firm fixed price with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (90-count units) under a firm fixed-price contract valued at $1,156.44. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025, and does not include a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQKADelivery Order
The Defense Logistics Agency awarded a $1,711.70 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, leverages its IDC with the Defense Logistics Agency to fulfill ongoing pharmaceutical requirements across the Department of Defense and other federal health systems. The company's contract portfolio demonstrates extensive experience delivering diverse therapeutic products, including psychiatric medications such as Escitalopram, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the operational flexibility of the DLA's pharmaceutical prime vendor model, which enables rapid fulfillment of specific medical supply needs through established contract vehicles while maintaining competitive procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/9/25 |